NEW YORK (GenomeWeb News) — Sloning Biotechnology of Puchheim, Germany, on Monday said that Research and Innovation Japan will exclusively market and distribute its Slonomics gene-synthesis service and its Slonomax gene-mutant libraries in Japan.
 
“Sloning's products and services perfectly address the current demand in genomics research and protein engineering,” RIJ CEO Kiyohiko Hirasawa said in a statement.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.